# CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES.

> **NIH NIH N01** · LOVELACE BIOMEDICAL RESEARCH INSTITUTE · 2024 · $133,039

## Abstract

CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES.

## Key facts

- **NIH application ID:** 11219862
- **Project number:** 75N95019D00012-P00006-759502000004-1
- **Recipient organization:** LOVELACE BIOMEDICAL RESEARCH INSTITUTE
- **Principal Investigator:** JOHN FARMER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $133,039
- **Award type:** —
- **Project period:** 2020-09-24 → 2024-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11219862

## Citation

> US National Institutes of Health, RePORTER application 11219862, CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES. (75N95019D00012-P00006-759502000004-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11219862. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*